Skip to main content
. 2022 Dec 7;2022(12):CD015477. doi: 10.1002/14651858.CD015477

41.

41

Analysis 5.1.3: heterologous vaccination scheme versus homologous vaccination scheme. Outcome: any adverse event (AE).

Liu 2021 included only participants 50 years of age or older.

Liu X 2021.1 and Liu X 2021.2 are different comparisons for the same report (Liu 2021).